Condition: Cystic Fibrosis Lung Disease · Sponsor: Heidelberg University
The purpose of this study is to further characterize early CF lung disease in newborns, infants and toddlers with cystic fibrosis (CF).
This description comes directly from the study's public registry record.
Marcus A Mall, MD · +49 6221 56 4502 · Marcus.Mall@med.uni-heidelberg.de
Mirjam Stahl, MD · +49 6221 56 37049 · Mirjam.Stahl@med.uni-heidelberg.de
Always discuss trial participation with your own doctor first.
| University Children's Hospital Heidelberg, Cystic Fibrosis Centre | Heidelberg, Baden-Wurttemberg, Germany | Recruiting |
| University Hospital Gießen and Marburg GmbH | Giessen, Hesse, Germany | Recruiting |
| Medizinische Hochschule Hannover | Hanover, Lower Saxony, Germany | Recruiting |
| University Children's Hospital Schleswig-Holstein | Lübeck, Schleswig-Holstein, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02270476